Cell-cycle checkpoints were originally defined as control mechanisms that ensured the dependence of one cell-cycle event on the completion of an earlier cell-cycle event (Hartwell and Weinert, 1989) . Two classic examples include the DNA damage checkpoint, which prevents entry into mitosis in the presence of DNA damage, and the spindle assembly checkpoint, which prevents the onset of anaphase prior to biorientation of all chromosomes on the mitotic spindle. These signaling mechanisms are essential to protecting the integrity of the genome.
Over the years, a number of new checkpoints have been proposed, including a "tetraploidy checkpoint" that prevents cell-cycle progression after failed cytokinesis. An expanding body of work, including studies in tissue culture cells, mouse models, and human patients, suggests that tetraploidy is a genetically unstable state that can precede the development of gross chromosomal aneuploidy and facilitate tumorigenesis (Ganem et al., 2007) . Many cell-cycle defects, including progression past DNA damage or spindle checkpoints, can lead to cytokinesis failure. Thus, it has been appealing to postulate that a tetraploidy checkpoint could serve as the "suspenders" to the "belts" of earlier cell-cycle checkpoints and provide a final opportunity for these potentially dangerous cells to be eliminated. The existence of such a checkpoint, however, and the implication that cells can actually "count" the number of chromosomes or centrosomes, has been challenged. Here, we review the evidence for and against a specific tetraploid checkpoint and describe progress in defining mechanisms that prevent the proliferation of tetraploid cells.
p53-Dependent Cell-Cycle Arrest of Tetraploid Cells
The first evidence that cells possessing tetraploid DNA content might have a limited capacity to proliferate was found over 30 years ago, long before the importance of cell-cycle checkpoint controls was appreciated. In 1967, it was discovered that chemical metabolites called cytochalasins (from the Greek words "cytos" meaning cell and "chalasis" meaning relaxation) prevented cytokinesis in mammalian cells and promoted the accumulation of binucleate tetraploid cells (Carter, 1967) . Subsequent work supported this initial finding as similar experiments in different cell types suggested that the majority of nontransformed cell lines accumulated as binucleate cells after cytochalasin-induced cytokinesis failure (Wright and Hayflick, 1972) . In contrast, mammalian cells transformed by the SV40 T antigen exposed to the same cytochalasin treatment did not arrest as binucleate tetraploids but rather continued to proliferate becoming multinucleate. These findings implied that there was some SV40-dependent control on cellular ploidy. As surmised by Wright and Hayflick (1972) : …once a normal human diploid cell becomes binucleate, intrinsic cell mechanisms come into play preventing further nuclear division. These cell mechanisms may be those altered by the change from a normal to a transformed state. Perhaps the SV40-transformed cells are able to continue nuclear division in the absence of cytokinesis because they have escaped from this control.
Indeed, this turned out to be true, as SV40 transformation was later shown to inactivate, among other proteins, p53, a key transcription factor that is necessary for G 1 cellcycle arrest.
Despite these intriguing early findings, the phenomenon of a p53-dependent cell-cycle arrest after cell division failure received little attention for the next 25 years. It was not until the mid-1990s that interest was rekindled, as several groups began to study the effects of spindle poisons-such as colchicine or nocodazole, which depolymerize microtubules-on cell proliferation. These poisons disrupt mitotic spindle assembly and induce cell-cycle arrest by activating the spindle checkpoint. However, after a period of arrest, cells exposed to these poisons adapt, proceed into the cell cycle, fail to undergo cytokinesis because they cannot segregate their chromosomes, and enter the G 1 phase as tetraploid cells, a series of steps now termed "mitotic slippage" (Rieder and Maiato, 2004) . The G 1 arrest of post-slippage tetraploid cells requires p53 and is often long-lasting, most likely because of the induction of cellular senescence (Rieder and Maiato, 2004) .
Studies of mitotic slippage left unresolved the question of why p53-proficient tetraploids arrest in G 1 following mitotic slippage. Do cells arrest directly in response to the increased chromosome content, or is the arrest secondary to some correlated (but undefined) defect? To address these questions, Andreassen et al. (2001) revisited the effects of cytochalasin. Consistent with the early work, transient dihydrocytochalasin B treatment resulted in G 1 -arrested binucleate tetraploid cells, and this arrest was p53-dependent. Because cells treated with dihydrocytochalasin B formed normal mitotic spindles and underwent normal anaphase, the authors inferred that the main effect of dihydrocytochalasin B was to block cytokinesis. Thus, based on the observation that tetraploid cells generated by independent means-mitotic slippage or cytokinetic failure-similarly arrested in G 1 , Andreassen et al. proposed that cells directly monitor chromosome or centrosome number and coined the term "tetraploidy checkpoint."
Cell-Cycle Progression in Tetraploids
Although the idea of a tetraploidy checkpoint is appealing, it has recently fallen out of favor. One confounding issue is that many tetraploid cells can, in fact, proliferate. For example, normal hepatocytes are often polyploid, and these cells are capable of undergoing mitoses with tetraploid or higher numbers of chromosome sets (Guidotti et al., 2003) . Additionally, genome duplications are frequently observed during the course of evolution, and many plants and amphibians can develop as newly generated polyploids (Storchova and Pellman, 2004 ; see Review by S. Otto on page 452 of this issue). Indeed, although higher vertebrates tolerate polyploidy poorly, there are rare reports of human tetraploid births (Storchova and Pellman, 2004) .
Another issue that complicates the tetraploidy checkpoint idea is whether the drug treatments and synchronization procedures used to generate tetraploids had other effects that might have been the real triggers of the G 1 arrest. This issue was suggested by a study showing that dihydrocytochalasin B at high concentrations could even arrest diploid cells in G 1 (Lohez et al., 2003) . Furthermore, cell-cycle arrest after induction of tetraploidy with cytochalasin is dependent on the concentration of drug used: whereas 10 µM cytochalasin generates binucleate tetraploid cells that arrest in G 1 , 0.5 µM cytochalasin produces binucleate cells that largely divide on schedule (Uetake and Sluder, 2004) . Other aspects of the culture conditions, such as the strength of substrate attachment via fibronectin, also influence whether binucleate cells arrest in G 1 or continue to divide. Consistent with the idea that tetraploid cells can divide normally with a tetraploid complement of chromosomes, tetraploids generated by cell fusion are capable of proliferating, at least for the first cell cycle after fusion (Wong and Stearns, 2005) . Finally, cells fused to centrosome-containing cellular fragments lacking nuclei, termed cytoplasts, can also proliferate. Thus, neither doubling the number of chromosomes nor doubling the number of centrosomes necessarily results in arrest in G 1 .
These findings make it unlikely that a specific checkpoint directly counts chromosome or centrosome numbers. However, the fact remains that many manipulations that produce tetraploid cells do in fact activate p53 and G 1 arrest. What is the trigger? Is it an ill-defined "offtarget" effect of the drugs, such as DNA damage? Although dihydrocytochalasin B by itself does not induce detectable DNA damage, a combination of drug treatments used to synchronize cells can (Wong and Stearns, 2005) . However, there are reasons to think that drug effects alone cannot be the whole story. For example, whereas binucleate cells generated by high concentrations of dihydrocytochalasin B undergo cellcycle arrest, mononucleate cells in the same culture do not (Uetake and Sluder, 2004) . Whatever the trigger for cell-cycle arrest, clearly binucleate cells are more sensitive. Furthermore, many p53-proficient spontaneously arising tetraploids also undergo cell-cycle arrest (Shi and King, 2005) . Together, these findings suggest that there is some, as yet undefined, "abnormality" in tetraploid cells, and that this defect(s) must feed into signaling pathways that activate p53.
Is Tetraploidy Stressful?
Several recent studies have shed light on how cytoskeletal defects can arrest the cell cycle in G 1 via p53 and offer important clues as to why tetraploid cells might also tend to arrest in G 1 . In addition to the wellunderstood effects of DNA damage, a variety of cellular stresses such as heat shock, osmotic shock, and inflammatory cytokines are also known to activate p53 and trigger G 1 cell-cycle arrest. A key mediator of the response to these stressors is the p38/MAP kinase family (Zarubin and Han, 2005); p38 phosphorylates, stabilizes, and activates p53, ultimately driving cell-cycle arrest, senescence, and/or apoptosis. Two recent studies demonstrated that abnormal centrosomes are a new kind of "stress" that can promote cell-cycle arrest through p38/MAP kinase. Depletion of pericentrin or PCM-1 (Srsen et al., 2006) or 14 of the 15 centrosomal components (Mikule et al., 2007) arrests cells via activation of p38, p38-dependent phosphorylation of p53, and accumulation of p53 at centrosomes and in the nucleus. As expected, active p53 induces the cyclin-dependent kinase inhibitor p21, thus blocking S phase entry. Pharmacological inhibition of p38 or genetic disruption of p53 or p21 abolishes the G 1 cellCell 131, November 2, 2007 ©2007 Elsevier Inc. 439 cycle arrest induced by centrosome defects. These results led Mikule et al. to suggest that disruption of centrosome structure and/or function activates a "centrosome damage" checkpoint that leads to a p38-dependent G 1 cell-cycle arrest.
New work demonstrates that cellcycle arrest can be achieved by the combined effect of several different cellular stressors. Sluder and colleagues have recently revisited their analysis of cell-cycle progression subsequent to microsurgical removal of centrosomes. In contrast to their earlier findings, the authors now report that nontransformed human cells lacking centrosomes do not necessarily activate a G 1 cellcycle arrest if cultured under the appropriate conditions, particularly if they are exposed to minimal levels of blue light (488 nm, used to image GFP) (Uetake et al., 2007) . However, high intensity 488 nm blue light does induce a p38/MAP kinase-dependent G 1 arrest in these cells. A careful analysis demonstrated that the stress caused by centrosome removal and blue light exposure is cumulative, and that it takes a combination of both factors to induce the full-blown p53-dependent G 1 arrest. These results illustrate a kind of "Heisenberg uncertainty principal" problem that must be considered when evaluating long-term imaging experiments: various cellular stresses may act collectively in cells, eventually crossing a threshold of p38 activation that imposes a p53-dependent G 1 arrest.
There are intriguing parallels between the story of acentrosomal cells and the tetraploidy checkpoint story. In both cases, early experiments, although state-of-the-art at the time, involved unappreciated "rough treatment" of cells-blue light in the case of centrosome removal and high doses of dihydrocytochalasin B in the case of the tetraploidy checkpoint studies. In both cases, the result was a strong cell-cycle arrest response. As more hospitable conditions were identified, it became clear that cell-cycle arrest was not an obligatory endpoint. Thus, although tetraploidy alone might be stressful, it is not sufficient stress to trigger cell-cycle arrest. Perhaps the spontaneous tetraploids imaged by Shi and King that failed to progress through the cell cycle did so because they were experiencing the combined effects of tetraploidy and imaging. An important test of this possibility will be to determine whether the cell-cycle arrest of tetraploids generated by high doses of dihydrocytochalasin B is mediated by p38/MAP kinase and to determine the potential contributions of imaging and tetraploidy to the arrest of spontaneous tetraploids.
If tetraploidy is a weak stressor, we are still left asking where the stress originates from. One candidate source are extra centrosomes, which could produce effects similar to those of defective centrosomes; for example, defects in centrosomebased signaling or subtle defects in microtubule organization. Another interesting possibility is abnormal actin and adhesion. This is supported by findings that inhibition of cell spreading blocks S phase entry (Ingber, 2003) and that increased fibronectin, and thus stronger adhesion, reduces the likelihood that tetraploid cells will arrest in G 1 (Uetake and Sluder, 2004) . Because of the extensive interconnections between the centrosome, microtubules, and actin, it will not be trivial to determine whether there is a single primary defect. Indeed, more than one form of "cytoskeletal stress" could feed into p38 or other signaling pathways.
A final interesting issue concerns the nature of the signaling molecules that sense cytoskeletal stress and trigger p38 activation. One recently identified new player is the tumor suppressor kinase Lats2. Spindle damage and subsequent mitotic slippage after nocodazole treatment cause translocation of Lats2 from the centrosome to the nucleus, where it activates p53 (Aylon et al., 2006) . Interestingly, p53 is activated shortly after microtubule damage, in the G 2 phase prior to mitotic slippage. Therefore, it appears that spindle damage can ramp up the cell-cycle arrest machinery, sensitizing cells to arrest in the subsequent G 1 . Whether Lats2 is activated in other circumstances where tetraploids are formed is not known. However, it is worth considering that centrosome disruption might similarly promote Lats2 nuclear translocation. Additional candidates for linking cytoskeletal defects to p38 and p53 are the Rho family of small GTPases: Cdc42 and Rac are known to be required for p38 activation in response to inflammatory cytokines (Zarubin and Han, 2005) .
The Fitness of Tetraploids
Clearly, tetraploids are prone to cell-cycle arrest via one or more pathways that activate p53. However, there is another important factor preventing the accumulation of polyploid cells: in many cases, polyploids are less fit than their diploid counterparts. For example, in budding yeast, diploids out-compete tetraploids in long-term culture (Mable, 2001) . Similarly, when diploid murine embryonic stem cells are introduced into tetraploid blastocysts, the diploid embryonic stem cells take over and produce a completely diploid fetus (Nagy et al., 1990) . Polyploid cells also undergo apoptosis at substantially higher rates than diploids, and prevention of apoptosis leads to a striking increase in the number of polyploid cells (Castedo et al., 2006) . Although increased ploidy generally results in a balanced increase in gene expression, tetraploid human colon cancer cells display a subtle increase in the expression of some p53-target genes, likely reflecting stress or DNA damage in a subset of cells (Castedo et al., 2006) .
Conclusions
In animals, the proliferation of tetraploid cells is limited by a variety of mechanisms. Tetraploid cells are generally less fit than their diploid counterparts, at least in part because of chromosome segregation errors and aneuploidy. Indeed, aneuploid cells are less fit then their euploid parents (Torres et al., 2007) . Without a rare transforming mutation, most tetraploid cells are expected to lose out in competition with diploids. In addition, tetraploid cells have a tendency to activate a p53 response that leads to G 1 arrest, and ultimately to senescence or apoptosis. It appears that there is no specific tetraploidy checkpoint, in the sense that cells have a mechanism to directly count chromosomes or centrosomes. However, a similar protective effect may be achieved by the activation of p53 triggered by other cellular abnormalities that accompany tetraploidy ( Figure  1 ). Although the nature of these abnormalities has not been clearly elucidated, we suggest that an important source of the underlying defect is the cytoskeleton. We have reviewed several studies suggesting that cytoskeletal abnormalities can trigger the activation of p38/ MAP kinase and thus induce p53-dependent G 1 cell-cycle arrest. An important emerging concept is that inputs into the p38 system are cumulative, explaining why in one experimental context a defect might trigger cell-cycle arrest whereas in other contexts it does not. If the main defect in tetraploid cells is a subtly abnormal cytoskeleton, then the response to this defect can be viewed as one facet of a more general signaling network to monitor the integrity and organization of the cytoskeleton. We are at an early stage in elucidating these signaling pathways, but a better understanding of these signaling networks should shed light on a variety of cellular processes in development and cancer.
